ING/WellPoint and Aetna may or may not be talking, but several Aetna shareholders definitely want them to. Following Aetna’s rejection of their bid, which analysts valued at close to $70 a share, Aetna announced that it intended to split into two companies. Its shares have since fallen to the low $50s, which is at least better that its eight-year low of $38.50 a share reached in February. The complaining shareholders thought the takeover rejection was an error and have filed suit against Aetna in a Connecticut Superior Court alleging that it refused to adequately consider the ING/WellPoint bid simply to protect current management.
Topics Lawsuits
Was this article valuable?
Here are more articles you may enjoy.
Good Times for US P/C Insurers May Not Last; Auto Challenges Ahead 
Nearly Half of 100 Largest P/C Insurers Destroy Value: ACORD 
’60 Minutes’ Homeowners Ask Court to Force DFS to Divulge Heritage Probe Info 
AIG’s Zaffino to Step Down as CEO as Aon’s Andersen Steps In From This Issue
